Summary

The global endothelial dysfunction market was valued at US$2.14 billion in 2023. The market value is expected to reach US$2.79 billion by 2029. Endothelial dysfunction is a pathological state of the endothelium, the thin layer of cells lining the blood vessels, which plays a crucial role in maintaining vascular health.

The global endothelial dysfunction market is poised for robust growth, driven by the rising prevalence of cardiovascular diseases, advancements in diagnostic and therapeutic technologies, increased awareness and understanding of endothelial health, and supportive government policies. These factors collectively create a favorable environment for the expansion of this market, promising improved healthcare outcomes for patients affected by endothelial dysfunction. Moreover, with the aging global population and lifestyle changes, such as unhealthy diets and sedentary behaviors, the prevalence of conditions like hypertension, atherosclerosis, and diabetes has surged. These conditions directly contribute to endothelial dysfunction, thereby escalating the demand for diagnostic and therapeutic interventions in this market. The market is expected to grow at a CAGR of approx. 5% during the forecasted period of 2024-2029.

Market Segmentation Analysis:

By Test Type: The report provides the bifurcation of the market into two segments based on the test type: Invasive Test and Non-Invasive Test. The invasive test type held the highest share of the market, whereas the non-invasive test type is expected to be the fastest-growing segment in the forecasted period. The invasive methods provide highly accurate and detailed information about the endothelial function and are particularly useful in research settings and in patients with complex cardiovascular conditions. The growth in the invasive tests segment is driven by advancements in catheter technology, improved safety profiles of these procedures, and their high diagnostic accuracy. On the other hand, the growth in the non-invasive tests segment is driven by the increasing awareness of cardiovascular health, the convenience and safety of these tests, and technological advancements in imaging and biomarker analysis. Non-invasive tests are particularly appealing for routine screenings, large-scale epidemiological studies, and longitudinal monitoring of endothelial function in clinical practice.

By Type: The report further assess the non-invasive test based on the following types: Flow Mediated Dilatory, Peripheral Arterial Tonometry, Venous Occlusion Plethysmography, Circulating Markers, and Others. Flow mediated dilatory test held the highest share of the non-invasive endothelial dysfunction market and is expected to be the fastest growing segment. Flow mediated dilatory (FMD) is highly regarded for its ability to provide direct insight into endothelial function and is extensively used in both clinical settings and research studies. The growth in this segment is driven by advancements in ultrasound technology, which have improved the accuracy and reproducibility of FMD measurements.

By Cause: The report further provides the segmentation based on the following causes: Hypertension, Hypercholesterolemia, Obesity, Diabetes, Behcet’s Disease, and Others. The hypertension segment held the highest share of the market and is expected to be the fastest-growing segment in the forecasted period. The increasing incidence of hypertension, driven by factors such as aging population, sedentary lifestyles, and poor dietary habits, is escalating the demand for diagnostic and therapeutic solutions for endothelial dysfunction. Effective management of hypertension involves monitoring and improving endothelial function, thereby driving the market for related diagnostics and treatments. Furthermore, public health initiatives and guidelines emphasizing the importance of controlling blood pressure to prevent cardiovascular complications are raising awareness and promoting early diagnosis and treatment of endothelial dysfunction, thus fueling market growth.

By End-User: The report provides the glimpse of the endothelial dysfunction market based on the following end-user: Hospital, Diagnostic Center, Clinic, and Others. Hospitals held the highest share of the market and is expected to be the fastest-growing segment in the forecasted period. Hospitals serve as primary care centers for patients with cardiovascular and chronic diseases, making them pivotal in the diagnosis and management of endothelial dysfunction. The advanced medical infrastructure and availability of specialized equipment in hospitals enable comprehensive diagnostic evaluations and treatment plans for patients. Additionally, hospitals are usually the first point of contact for emergency cases, where conditions like acute coronary syndromes or strokes require immediate assessment of endothelial health.

By Region: The report provides insight into the endothelial dysfunction market based on the regions: North America, Europe, Asia Pacific, and Rest of the World. North America held the major share of the market. In the US, the growth of the endothelial dysfunction market is particularly pronounced. The high incidence of lifestyle-related diseases such as hypertension, obesity, and diabetes, which are major risk factors for endothelial dysfunction, is a primary contributor. The Centers for Disease Control and Prevention (CDC) report that nearly half of the adult population in the US has hypertension, a condition closely linked to endothelial dysfunction. The advanced healthcare system in the US, characterized by state-of-the-art medical facilities and widespread access to healthcare services, plays a crucial role in the market's expansion.

Germany’s advanced healthcare system, characterized by cutting-edge medical technology and comprehensive healthcare services, supports the widespread use of diagnostic and therapeutic solutions for endothelial dysfunction. The country has a strong tradition of medical research and innovation, supported by institutions like the Max Planck Society and the Fraunhofer Society. These institutions conduct extensive research on cardiovascular health and endothelial dysfunction, leading to the development of new treatments and diagnostic tools.

The Chinese government's support for research and innovation, exemplified by initiatives like the Healthy China 2030 plan, is fostering advancements in medical technology and treatments. Additionally, the aging population in China, with a growing number of elderly individuals, is contributing to the increased prevalence of endothelial dysfunction and related conditions. The combination of these factors, including rising disease prevalence, improved healthcare infrastructure, supportive government policies, and a strong focus on research and innovation, is driving the growth of the endothelial dysfunction market in China.

Market Dynamics:

Growth Drivers: The global endothelial dysfunction market has been growing over the past few years, due to factors such as rising incidence of obesity and diabetes, growing geriatric population, surge in healthcare expenditure, rising spending on pharmaceutical R&D, increasing prevalence of cardiovascular diseases, favorable government initiatives, and many other factors. The increasing prevalence of cardiovascular diseases (CVD) is a significant growth driver for the endothelial dysfunction market. Endothelial dysfunction, characterized by impaired endothelium-dependent vasodilation, is a key pathophysiological mechanism in CVD, contributing to atherosclerosis, hypertension, and heart failure. As more than 184 million people in the US are projected to develop some form of CVD, exceeding 61% of the population, the demand for diagnostic and therapeutic interventions targeting endothelial dysfunction is expected to rise substantially. According to the American Heart Association, CVD-related costs will triple to US$1.8 trillion by 2050, further emphasizing the economic burden and the need for effective management strategies.

Challenges: However, the market growth would be negatively impacted by various challenges such as limited diagnostic techniques, high cost, etc. The techniques for screening endothelial dysfunction, while pivotal in early diagnosis and intervention, present significant challenges that impact the endothelial dysfunction market. Key screening methods, such as flow-mediated dilation (FMD), peripheral arterial tonometry (PAT), and biomarkers assays, often suffer from limitations related to accuracy, reproducibility, and standardization. Flow-mediated dilation, considered a gold standard, requires high operator skill and is susceptible to variability based on patient conditions and procedural nuances. This variability undermines its reliability and hampers widespread clinical adoption.

Trends: The market is projected to grow at a fast pace during the forecast period, due to various latest trends such as integration artificial intelligence and big data analytics in healthcare, personalized medicine, rising usage of novel biomarkers and therapeutic approaches, rising use of noninvasive methods to assess endothelial dysfunction, emergence of regenerative medicine and gene therapy, rise in telemedicine and remote monitoring, focus on lifestyle interventions, etc. The rising usage of novel biomarkers and therapeutic strategies represents a significant trend in the endothelial dysfunction market. As research elucidates the pathophysiological mechanisms underlying endothelial dysfunction and atherosclerosis, novel biomarkers are being identified to improve risk stratification, early disease detection, and therapeutic monitoring. These biomarkers offer valuable insights into the molecular basis of atherosclerosis and serve as potential targets for preventive and therapeutic interventions.

Impact Analysis of COVID-19 and Way Forward:

In 2020, the initial impact of COVID-19 was marked by widespread disruptions in healthcare systems worldwide. Elective procedures were postponed, and non-urgent medical consultations were deferred, leading to a temporary decline in routine diagnosis and treatment of endothelial dysfunction. However, the subsequent recognition of the virus’s impact on vascular health catalyzed growth and innovation in the market by 2021. The post-COVID-19 era has seen a sustained and enhanced focus on endothelial dysfunction, driven by advancements in research, diagnostics, and digital health solutions.

Competitive Landscape:

The global endothelial dysfunction industry is competitive landscape characterized by a mix of established players, emerging startups, and technological innovations. The key players in the global endothelial dysfunction market are:

ZOLL Medical Corporation (Itamar Medical)
Perimed AB
SMART Medical Limited
Everist Health Inc.
Endothelix, Inc.

Various companies are focusing on organic growth strategies such as launches, approvals, and other enhancements. Inorganic growth strategies witnessed in the market were mergers & acquisitions, partnership, expansion, and collaborations. These activities have paved way for expansion of business and customer base of market players. For instance, in April 2023, Perimed had signed an agreement with Lovell Government Services. Lovell’s customers are Federal, State, and Local Governments such as the Department of Veteran Affairs (VA), Defense Logistics Agency, and Department of Defense in the US. With this agreement, Perimed gains an additional sales channel as Lovell would notify the company of any government contract opportunities within its field of business and bid on Perimed’s behalf. Furthermore, in April 2021, Berkeley Lab had developed flow-mediated dilation device to monitor both endothelial function and endothelium-independent vasodilation.

ページTOPに戻る

Table of Contents

1. Executive Summary

2. Introduction

2.1 Endothelial Dysfunction: An Overview
2.1.1 Introduction to Endothelial Dysfunction
2.1.2 Symptoms of Endothelial Dysfunction

2.2 Endothelial Dysfunction Segmentation: An Overview

3. Global Market Analysis

3.1 Global Endothelial Dysfunction Market: An Analysis

3.1.1 Global Endothelial Dysfunction Market: An Overview
3.1.2 Global Endothelial Dysfunction Market by Value
3.1.3 Global Endothelial Dysfunction Market by Test Type (Invasive Test and Non-Invasive Test)
3.1.4 Global Endothelial Dysfunction Market by Cause (Hypertension, Hypercholesterolemia, Obesity, Diabetes, Behcet’s Disease, and Others)
3.1.5 Global Endothelial Dysfunction Market by End-User (Hospital, Diagnostic Center, Clinic, and Others)
3.1.6 Global Endothelial Dysfunction Market by Region (North America, Europe, Asia Pacific, and Rest of the World)

3.2 Global Endothelial Dysfunction Market: Test Type Analysis

3.2.1 Global Endothelial Dysfunction Market by Test Type: An Overview
3.2.2 Global Endothelial Dysfunction Invasive Test Market by Value
3.2.3 Global Endothelial Dysfunction Non-Invasive Test Market by Value
3.2.4 Global Endothelial Dysfunction Non-Invasive Test Market by Type (Flow Mediated Dilatory, Peripheral Arterial Tonometry, Venous Occlusion Plethysmography, Circulating Markers, and Others)
3.2.5 Global Flow Mediated Dilatory Endothelial Dysfunction Non-Invasive Test Market by Value
3.2.6 Global Peripheral Arterial Tonometry Endothelial Dysfunction Non-Invasive Test Market by Value
3.2.7 Global Venous Occlusion Plethysmography Endothelial Dysfunction Non-Invasive Test Market by Value
3.2.8 Global Circulating Markers Endothelial Dysfunction Non-Invasive Test Market by Value
3.2.9 Global Other Endothelial Dysfunction Non-Invasive Test Market by Value

3.3 Global Endothelial Dysfunction Market: Cause Analysis

3.3.1 Global Endothelial Dysfunction Market by Cause: An Overview
3.3.2 Global Hypertension Endothelial Dysfunction Market by Value
3.3.3 Global Hypercholesterolemia Endothelial Dysfunction Market by Value
3.3.4 Global Obesity Endothelial Dysfunction Market by Value
3.3.5 Global Diabetes Endothelial Dysfunction Market by Value
3.3.6 Global Behcet's Disease Endothelial Dysfunction Market by Value
3.3.7 Global Others Endothelial Dysfunction Market by Value

3.4 Global Endothelial Dysfunction Market: End-User Analysis

3.4.1 Global Endothelial Dysfunction Market by End-User: An Overview
3.4.2 Global Hospital Endothelial Dysfunction Market by Value
3.4.3 Global Diagnostic Center Endothelial Dysfunction Market by Value
3.4.4 Global Clinic Endothelial Dysfunction Market by Value
3.4.5 Global Others Endothelial Dysfunction Market by Value

4. Regional Market Analysis

4.1 North America Endothelial Dysfunction Market: An Analysis

4.1.1 North America Endothelial Dysfunction Market: An Overview
4.1.2 North America Endothelial Dysfunction Market by Value
4.1.3 North America Endothelial Dysfunction Market by Test Type (Invasive Test and Non-Invasive Test)
4.1.4 North America Endothelial Dysfunction Market Test Type by Value
4.1.5 North America Endothelial Dysfunction Market by Cause (Hypertension, Hypercholesterolemia, Obesity, Diabetes, Behcet’s Disease, and Others)
4.1.6 North America Endothelial Dysfunction Market Cause by Value
4.1.7 North America Endothelial Dysfunction Market by End-User (Hospital, Diagnostic Center, Clinic, and Others)
4.1.8 North America Endothelial Dysfunction Market End-User by Value
4.1.9 North America Endothelial Dysfunction Market by Region (The US, Canada, and Mexico)
4.1.10 The US Endothelial Dysfunction Market by Value
4.1.11 The US Endothelial Dysfunction Market by Test Type (Invasive Test and Non-Invasive Test)
4.1.12 The US Endothelial Dysfunction Market by Cause (Hypertension, Hypercholesterolemia, Obesity, Diabetes, Behcet’s Disease, and Others)
4.1.13 The US Endothelial Dysfunction Market by End-User (Hospital, Diagnostic Center, Clinic, and Others)
4.1.14 Canada Endothelial Dysfunction Market by Value
4.1.15 Canada Endothelial Dysfunction Market by Test Type (Invasive Test and Non-Invasive Test)
4.1.16 Canada Endothelial Dysfunction Market by Cause (Hypertension, Hypercholesterolemia, Obesity, Diabetes, Behcet’s Disease, and Others)
4.1.17 Canada Endothelial Dysfunction Market by End-User (Hospital, Diagnostic Center, Clinic, and Others)
4.1.18 Mexico Endothelial Dysfunction Market by Value
4.1.19 Mexico Endothelial Dysfunction Market by Test Type (Invasive Test and Non-Invasive Test)
4.1.20 Mexico Endothelial Dysfunction Market by Cause (Hypertension, Hypercholesterolemia, Obesity, Diabetes, Behcet’s Disease, and Others)
4.1.21 Mexico Endothelial Dysfunction Market by End-User (Hospital, Diagnostic Center, Clinic, and Others)

4.2 Europe Endothelial Dysfunction Market: An Analysis

4.2.1 Europe Endothelial Dysfunction Market: An Overview
4.2.2 Europe Endothelial Dysfunction Market by Value
4.2.3 Europe Endothelial Dysfunction Market by Region (Germany, UK, France, Italy, Spain, and Rest of the Europe)
4.2.4 Germany Endothelial Dysfunction Market by Value
4.2.5 The UK Endothelial Dysfunction Market by Value
4.2.6 France Endothelial Dysfunction Market by Value
4.2.7 Italy Endothelial Dysfunction Market by Value
4.2.8 Spain Endothelial Dysfunction Market by Value
4.2.9 Rest of Europe Endothelial Dysfunction Market by Value

4.3 Asia Pacific Endothelial Dysfunction Market: An Analysis

4.3.1 Asia Pacific Endothelial Dysfunction Market: An Overview
4.3.2 Asia Pacific Endothelial Dysfunction Market by Value
4.3.3 Asia Pacific Endothelial Dysfunction Market by Region (China and Rest of Asia Pacific)
4.3.4 China Endothelial Dysfunction Market by Value
4.3.5 Rest of Asia Pacific Endothelial Dysfunction Market by Value

4.4 Rest of the World Endothelial Dysfunction Market: An Analysis

4.4.1 Rest of the World Endothelial Dysfunction Market: An Overview
4.4.2 Rest of the World Endothelial Dysfunction Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19 on Global Endothelial Dysfunction Market
5.2 Post COVID-19 Impact on Global Endothelial Dysfunction Market

6. Market Dynamics

6.1 Growth Drivers
6.1.1 Rising Incidence of Obesity and Diabetes
6.1.2 Growing Geriatric Population
6.1.3 Surge in Healthcare Expenditure
6.1.4 Rising Spending on Pharmaceutical R&D
6.1.5 Increasing Prevalence of Cardiovascular Diseases
6.1.6 Surge in Air Pollution
6.1.7 Favorable Government Initiatives

6.2 Challenges
6.2.1 Limited Diagnostic Techniques
6.2.2 High Cost

6.3 Market Trends
6.3.1 Integration Artificial Intelligence and Big Data Analytics in Healthcare
6.3.2 Personalized Medicine
6.3.3 Rising Usage of Novel Biomarkers and Therapeutic Approaches
6.3.4 Use of Noninvasive Methods to Assess Endothelial Dysfunction
6.3.5 Emergence of Regenerative Medicine and Gene Therapy
6.3.6 Rise in Telemedicine and Remote Monitoring
6.3.7 Focus on Lifestyle Interventions

7. Competitive Landscape

7.1 Global Endothelial Dysfunction Market: Competitive Landscape
7.2 Global Endothelial Dysfunction Market: Product Comparison

8. Company Profiles

8.1 ZOLL Medical Corporation (Itamar Medical)
8.1.1 Business Overview
8.1.2 Business Strategy

8.2 Perimed AB
8.2.1 Business Overview
8.2.2 Business Strategy

8.3 SMART Medical Limited
8.3.1 Business Overview
8.3.2 Business Strategy

8.4 Everist Health Inc.
8.4.1 Business Overview

8.5 Endothelix, Inc.
8.5.1 Business Overview

List of Figures

Figure 1: Symptoms of Endothelial Dysfunction
Figure 2: Endothelial Dysfunction Segmentation
Figure 3: Global Endothelial Dysfunction Market by Value; 2019-2023 (US$ Billion)
Figure 4: Global Endothelial Dysfunction Market by Value; 2024-2029 (US$ Billion)
Figure 5: Global Endothelial Dysfunction Market by Test Type; 2023 (Percentage, %)
Figure 6: Global Endothelial Dysfunction Market by Cause; 2023 (Percentage, %)
Figure 7: Global Endothelial Dysfunction Market by End-User; 2023 (Percentage, %)
Figure 8: Global Endothelial Dysfunction Market by Region; 2023 (Percentage, %)
Figure 9: Global Endothelial Dysfunction Invasive Test Market by Value; 2019-2023 (US$ Billion)
Figure 10: Global Endothelial Dysfunction Invasive Test Market by Value; 2024-2029 (US$ Billion)
Figure 11: Global Endothelial Dysfunction Non-Invasive Test Market by Value; 2019-2023 (US$ Million)
Figure 12: Global Endothelial Dysfunction Non-Invasive Test Market by Value; 2024-2029 (US$ Million)
Figure 13: Global Endothelial Dysfunction Non-Invasive Test Market by Type; 2023 (Percentage, %)
Figure 14: Global Flow Mediated Dilatory Endothelial Dysfunction Non-Invasive Test Market by Value; 2019-2023 (US$ Million)
Figure 15: Global Flow Mediated Dilatory Endothelial Dysfunction Non-Invasive Test Market by Value; 2024-2029 (US$ Million)
Figure 16: Global Peripheral Arterial Tonometry Endothelial Dysfunction Non-Invasive Test Market by Value; 2019-2023 (US$ Million)
Figure 17: Global Peripheral Arterial Tonometry Endothelial Dysfunction Non-Invasive Test Market by Value; 2024-2029 (US$ Million)
Figure 18: Global Venous Occlusion Plethysmography Endothelial Dysfunction Non-Invasive Test Market by Value; 2019-2023 (US$ Million)
Figure 19: Global Venous Occlusion Plethysmography Endothelial Dysfunction Non-Invasive Test Market by Value; 2024-2029 (US$ Million)
Figure 20: Global Circulating Markers Endothelial Dysfunction Non-Invasive Test Market by Value; 2019-2023 (US$ Million)
Figure 21: Global Circulating Markers Endothelial Dysfunction Non-Invasive Test Market by Value; 2024-2029 (US$ Million)
Figure 22: Global Other Endothelial Dysfunction Non-Invasive Test Market by Value; 2019-2023 (US$ Million)
Figure 23: Global Other Endothelial Dysfunction Non-Invasive Test Market by Value; 2024-2029 (US$ Million)
Figure 24: Global Hypertension Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 25: Global Hypertension Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 26: Global Hypercholesterolemia Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 27: Global Hypercholesterolemia Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 28: Global Obesity Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 29: Global Obesity Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 30: Global Diabetes Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 31: Global Diabetes Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 32: Global Behcet's Disease Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 33: Global Behcet's Disease Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 34: Global Others Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 35: Global Others Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 36: Global Hospital Endothelial Dysfunction Market by Value; 2019-2023 (US$ Billion)
Figure 37: Global Hospital Endothelial Dysfunction Market by Value; 2024-2029 (US$ Billion)
Figure 38: Global Diagnostic Center Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 39: Global Diagnostic Center Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 40: Global Clinic Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 41: Global Clinic Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 42: Global Others Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 43: Global Others Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 44: North America Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 45: North America Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 46: North America Endothelial Dysfunction Market by Test Type; 2023 (Percentage, %)
Figure 47: North America Endothelial Dysfunction Market Test Type by Value; 2019-2023 (US$ Million)
Figure 48: North America Endothelial Dysfunction Market Test Type by Value; 2024-2029 (US$ Million)
Figure 49: North America Endothelial Dysfunction Market by Cause; 2023 (Percentage, %)
Figure 50: North America Endothelial Dysfunction Market Cause by Value; 2019-2023 (US$ Million)
Figure 51: North America Endothelial Dysfunction Market Cause by Value; 2024-2029 (US$ Million)
Figure 52: North America Endothelial Dysfunction Market by End-User; 2023 (Percentage, %)
Figure 53: North America Endothelial Dysfunction Market End-User by Value; 2019-2023 (US$ Million)
Figure 54: North America Endothelial Dysfunction Market End-User by Value; 2024-2029 (US$ Million)
Figure 55: North America Endothelial Dysfunction Market by Region; 2023 (Percentage, %)
Figure 56: The US Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 57: The US Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 58: The US Endothelial Dysfunction Market by Test Type; 2023 and 2029 (Percentage, %)
Figure 59: The US Endothelial Dysfunction Market by Cause; 2023 and 2029 (Percentage, %)
Figure 60: The US Endothelial Dysfunction Market by End-User; 2023 and 2029 (Percentage, %)
Figure 61: Canada Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 62: Canada Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 63: Canada Endothelial Dysfunction Market by Test Type; 2023 and 2029 (Percentage, %)
Figure 64: Canada Endothelial Dysfunction Market by Cause; 2023 and 2029 (Percentage, %)
Figure 65: Canada Endothelial Dysfunction Market by End-User; 2023 and 2029 (Percentage, %)
Figure 66: Mexico Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 67: Mexico Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 68: Mexico Endothelial Dysfunction Market by Test Type; 2023 and 2029 (Percentage, %)
Figure 69: Mexico Endothelial Dysfunction Market by Cause; 2023 and 2029 (Percentage, %)
Figure 70: Mexico Endothelial Dysfunction Market by End-User; 2023 and 2029 (Percentage, %)
Figure 71: Europe Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 72: Europe Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 73: Europe Endothelial Dysfunction Market by Region; 2023 (Percentage, %)
Figure 74: Germany Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 75: Germany Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 76: The UK Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 77: The UK Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 78: France Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 79: France Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 80: Italy Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 81: Italy Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 82: Spain Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 83: Spain Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 84: Rest of Europe Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 85: Rest of Europe Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 86: Asia Pacific Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 87: Asia Pacific Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 88: Asia Pacific Endothelial Dysfunction Market by Region; 2023 (Percentage, %)
Figure 89: China Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 90: China Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 91: Rest of Asia Pacific Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 92: Rest of Asia Pacific Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 93: Rest of the World Endothelial Dysfunction Market by Value; 2019-2023 (US$ Million)
Figure 94: Rest of the World Endothelial Dysfunction Market by Value; 2024-2029 (US$ Million)
Figure 95: Global Adults with Overweight or Obesity as a Proportion of all Adults; 2020-2035 (Percentage, %)
Figure 96: Global Number Of Persons Aged 65 Years and Over By Development Group; 2023 & 2050 (Million)
Figure 97: The US National Health Expenditure Per Capita; 2020-2031 (US$ Thousand)
Figure 98: Global Spending on Pharmaceutical Research and Development; 2019-2028 (US$ Billion)
Figure 99: Global Artificial intelligence (AI) in Healthcare Market Size; 2021-2030 (US$ Billion)
Table 1: Global Endothelial Dysfunction Market: Product Comparison